Featured Research

from universities, journals, and other organizations

Celera Genomics Completes Sequencing Phase Of The Genome From One Human Being

Date:
April 7, 2000
Source:
Celera Genomics
Summary:
Celera Genomics has announced that it has completed the sequencing phase of one person’s genome and will now begin to assemble the sequenced fragments of the genome into their proper order based on new computational advances. Celera began to sequence the human genome seven months ago in September 1999. In addition to assembly, the company will now focus on annotating the sequence information and collecting additional data on genetic variations.

Company Begins Sequencing Mouse Genome

Related Articles


ROCKVILLE, MD -- April 6, 2000 -- Celera Genomics (NYSE: CRA), a PE Corporation business, announced today that it has completed the sequencing phase of one person’s genome and will now begin to assemble the sequenced fragments of the genome into their proper order based on new computational advances. Celera began to sequence the human genome seven months ago in September 1999. In addition to assembly, the company will now focus on annotating the sequence information and collecting additional data on genetic variations.

Celera’s whole genome shotgun sequencing technique involves sequencing from both ends of the double stranded cloned DNA. Celera’s accurately paired clone end sequences are a key tool for assembling the genome much more completely than single stranded sequencing methods allow at comparable levels of sequence coverage. Celera’s paired end-sequencing strategy, as part of the whole genome shotgun sequencing technique, has now produced sequence pairs from clones that cover the human genome 11 times. The company believes that 99% of the human genome is represented in the cloned DNA.

Celera’s whole genome sequencing strategy has been validated by the recent publication of the Drosophila melanogaster (fruit fly) genome, the largest genome to be sequenced and assembled to date. Drosophila is a very important model for human biology and medicine. After assembly and annotation, the non-repetitive regions of the Drosophila genome have greater than 99.99% sequence accuracy.

Celera has finished the human genome sequencing phase and has started the assembly of the genome, but the company will continue to perform human sequencing for SNP (single nucleotide polymorphisms) diversity and for gap closure. The SNPs are single letter variations between people that determine susceptibility to disease and the ability to combat illness. A significant feature of Celera’s approach to sequencing the human genome is the use of genetic material from both men and women of various ethnic backgrounds. When Celera completes human SNP sequencing over the next few months, its genomic database will consist of data from six men and women of varying self-identified ethnic backgrounds. This approach should allow Celera to develop a database for studying the genetic variations between individuals at the same time the genome is being deciphered. "Now that we have completed the sequencing of one human being’s genome we will turn our computational power to the task of ordering the human genome," said J. Craig Venter, Ph.D., Celera’s president and chief scientific officer. "We intend to complete and publish the human data in a form that is consistent with the high-quality Drosophila genome that Celera achieved in collaboration with the Berkeley Drosophila Genome Project. This is expected to allow researchers worldwide and our subscribers to utilize our data to make important medical advances."

Celera Starts Mouse Genome Project

Celera has now begun the mouse genome project, which is of critical importance to biomedical researchers using the mouse as a model for studies of human biology and medicine. A key feature of Celera’s business model will be the ability to compare genomes from various organisms (comparative genomics). The comparison of the mouse, Drosophila, and human genomes is expected to open many new avenues of research into the mechanisms of gene conservation and regulation, which could lead to a better understanding of gene function and disease.

Celera Milestones

* Human Genome:

On January 10, 2000, Celera announced it had compiled data covering 90% of the human genome. With the announcement today, Celera is on target to complete the assembly and annotation of the human genome later this year.

* Drosophila melanogaster Genome:

On December 30, 1999, Celera completed the release of the Drosophila genome sequence to the public data bank. After doing extensive scientific analysis in conjunction with the Berkeley Drosophila Genome Project (BDGP) and other collaborators, Celera and the public collaborators published the manuscripts in the scientific journal Science on March 24, 2000. Celera and its collaborators have identified nearly 14,000 genes in the genome, many in commercially important protein families, which should prove valuable in developing new therapeutics and insecticides. Drosophila is the largest genome sequenced to date, and is the first insect and the first organism with a central nervous system to be sequenced.

PE Corporation currently comprises two operating groups. Celera Genomics Group, headquartered in Rockville, MD, intends to become the definitive source of genomic and related medical information. PE Biosystems Group (NYSE: PEB), headquartered in Foster City, CA and with sales of $1.2 billion during fiscal 1999, develops and markets instrument-based systems, reagents, software, and contract related services to the life science industry and research community. Information about the company, including consolidated financial statements of PE Corporation, is available on the World Wide Web at http://www.pecorporation.com or by phoning (800) 762-6923.


Story Source:

The above story is based on materials provided by Celera Genomics. Note: Materials may be edited for content and length.


Cite This Page:

Celera Genomics. "Celera Genomics Completes Sequencing Phase Of The Genome From One Human Being." ScienceDaily. ScienceDaily, 7 April 2000. <www.sciencedaily.com/releases/2000/04/000406135257.htm>.
Celera Genomics. (2000, April 7). Celera Genomics Completes Sequencing Phase Of The Genome From One Human Being. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2000/04/000406135257.htm
Celera Genomics. "Celera Genomics Completes Sequencing Phase Of The Genome From One Human Being." ScienceDaily. www.sciencedaily.com/releases/2000/04/000406135257.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins